Abstract
EDITOR, - The Legal Aid Board recently published a report on multiparty actions.1 This has wide implications for medical and pharmaceutical litigation. It is usual for the board to rely on the advice of plaintiff lawyers in deciding whether to fund medical and pharmaceutical claims. Such advice cannot be independent as the lawyers have a financial interest in advancing the claim. The board asserts, “it is wrong to assume …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
